Needle and syringe programmes

Needle and syringe programmes (NSPs) are public health initiatives that aim to reduce the spread of infectious diseases, particularly HIV and hepatitis C, among intravenous drug users. These programmes provide sterile needles and syringes to individuals who inject drugs, in an effort to prevent the sharing and reuse of injection equipment, which can transmit these diseases.

History

The first NSP was established in Amsterdam in 1984, in response to concerns about the spread of HIV among the city's drug-using population. The success of this programme led to the establishment of similar initiatives in other countries, including the United Kingdom, Australia, and the United States.

Effectiveness

Numerous studies have demonstrated the effectiveness of NSPs in reducing the spread of infectious diseases. A 2012 review by the World Health Organization found that NSPs significantly reduce HIV transmission and do not increase drug use. Similarly, a 2014 review in the British Medical Journal concluded that NSPs are associated with decreases in the prevalence of hepatitis C.

Criticism and controversy

Despite their demonstrated effectiveness, NSPs have been the subject of controversy. Critics argue that these programmes condone and enable drug use. However, proponents of NSPs argue that they are a pragmatic response to a public health issue, and that they can serve as a bridge to other services, such as drug treatment and counseling.

See also

• Harm reduction
• Drug policy
• Opioid epidemic

   This article is a Public health stub. You can help WikiMD by expanding it!

This harm reduction related article is a stub. You can help WikiMD by expanding it.

This drug policy related article is a stub. You can help WikiMD by expanding it.